doi:10.1007/s12250-016-3918-y

Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N, Soeroso S, Uyeki TM, 2008: Update on avian influenza A (H5N1) virus infection in humans[J]. N Engl J Med, 358, 261-273. doi: 10.1056/NEJMra0707279
Achdout H, Manaster I, Mandelboim O, 2008: Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins[J]. J Virol, 82, 8030-8037. doi: 10.1128/JVI.00870-08
Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O, 2005: Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus[J]. Nat Immunol, 6, 515-523.
Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A, Kedar E, Porgador A, Mandelboim O, 2004: The mechanisms controlling the recognition of tumor-and virus-infected cells by NKp46[J]. Blood, 103, 664-672. doi: 10.1182/blood-2003-05-1716
Bar-On Y, Seidel E, Tsukerman P, Mandelboim M, Mandelboim O, 2014: Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors[J]. J Infect Dis, 210, 410-418. doi: 10.1093/infdis/jiu094
Chehimi J, Bandyopadhyay S, Prakash K, Perussia B, Hassan NF, Kawashima H, Campbell D, Kornbluth J, Starr SE, 1991: In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates[J]. J Virol, 65, 1812-1822.
Cooper MA, Fehniger TA, Caligiuri MA, 2001: The biology of human natural killer-cell subsets[J]. Trends Immunol, 22, 633-640. doi: 10.1016/S1471-4906(01)02060-9
Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Valiante NM, 2002: Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein[J]. J Exp Med, 195, 35-41. doi: 10.1084/jem.20011124
de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J, 2006: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia[J]. Nat Med, 12, 1203-1207. doi: 10.1038/nm1477
Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D, Moretta A, Valiante NM, Parham P, 2007: NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection[J]. J Immunol, 178, 2688-2698. doi: 10.4049/jimmunol.178.5.2688
Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, Yuen T, Sealfon SC, Garcia-Sastre A, Moran TM, 2006: Influenza virus evades innate and adaptive immunity via the NS1 protein[J]. J Virol, 80, 6295-6304. doi: 10.1128/JVI.02381-05
Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y, 2008: Human infection with highly pathogenic H5N1 influenza virus[J]. Lancet, 371, 1464-1475. doi: 10.1016/S0140-6736(08)60627-3
Guo H, Kumar P, Moran TM, Garcia-Sastre A, Zhou Y, Malarkannan S, 2009: The functional impairment of natural killer cells during influenza virus infection[J]. Immunol Cell Biol, 87, 579-589. doi: 10.1038/icb.2009.60
Isobe Y, Sugimoto K, Yang L, Tamayose K, Egashira M, Kaneko T, Takada K, Oshimi K, 2004: Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells[J]. Cancer Res, 64, 2167-2174. doi: 10.1158/0008-5472.CAN-03-1562
Jonjic S, Babic M, Polic B, Krmpotic A, 2008: Immune evasion of natural killer cells by viruses[J]. Curr Opin Immunol, 20, 30-38. doi: 10.1016/j.coi.2007.11.002
Katze MG, Fornek JL, Palermo RE, Walters KA, Korth MJ, 2008: Innate immune modulation by RNA viruses: emerging insights from functional genomics[J]. Nat Rev Immunol, 8, 644-654. doi: 10.1038/nri2377
Li J, Li H, Mao H, Yu M, Yang F, Feng T, Fan Y, Lu Q, Shen C, Yin Z, Mao M, Tu W, 2013: Impaired NK cell antiviral cytokine response against influenza virus in small-for-gestational-age neonates[J]. Cell Mol Immunol, 10, 437-443. doi: 10.1038/cmi.2013.31
Lodoen MB, Lanier LL, 2005: Viral modulation of NK cell immunity[J]. Nat Rev Microbiol, 3, 59-69. doi: 10.1038/nrmicro1066
Lodoen MB, Lanier LL, 2006: Natural killer cells as an initial defense against pathogens[J]. Curr Opin Immunol, 18, 391-398. doi: 10.1016/j.coi.2006.05.002
Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A, 2001: Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells[J]. Nature, 409, 1055-1060. doi: 10.1038/35059110
Mao H, Tu W, Liu Y, Qin G, Zheng J, Chan PL, Lam KT, Peiris JS, Lau YL, 2010: Inhibition of human natural killer cell acti-vity by influenza virions and hemagglutinin[J]. J Virol, 84, 4148-4157. doi: 10.1128/JVI.02340-09
Mao H, Tu W, Qin G, Law HK, Sia SF, Chan PL, Liu Y, Lam KT, Zheng J, Peiris M, Lau YL, 2009: Influenza virus directly infects human natural killer cells and induces cell apoptosis[J]. J Virol, 83, 9215-9222. doi: 10.1128/JVI.00805-09
Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD, 2004: Human and avian influenza viruses target different cell types in cultures of human airway epithelium[J]. Proc Natl Acad Sci U S A, 101, 4620-4624. doi: 10.1073/pnas.0308001101
Nguyen TH, Farrar J, Horby P, 2008: Person-to-person transmission of influenza A (H5N1)[J]. Lancet, 371, 1392-1394. doi: 10.1016/S0140-6736(08)60494-8
Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL, 2002: Viral evasion of natural killer cells[J]. Nat Immunol, 3, 1006-1012. doi: 10.1038/ni1102-1006
Owen RE, Yamada E, Thompson CI, Phillipson LJ, Thompson C, Taylor E, Zambon M, Osborn HM, Barclay WS, Borrow P, 2007: Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells[J]. J Virol, 81, 11170-11178. doi: 10.1128/JVI.01217-07
Parker AK, Yokoyama WM, Corbett JA, Chen N, Buller RM, 2008: Primary naive and interleukin-2-activated natural killer cells do not support efficient ectromelia virus replication[J]. J Gen Virol, 89, 751-759. doi: 10.1099/vir.0.83205-0
Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y, 2004: Re-emergence of fatal human influenza A subtype H5N1 disease[J]. Lancet, 363, 617-619. doi: 10.1016/S0140-6736(04)15595-5
Peruzzi M, Azzari C, Rossi ME, De Martino M, Vierucci A, 2000: Inhibition of natural killer cell cytotoxicity and interferon gamma production by the envelope protein of HIV and prevention by vasoactive intestinal peptide[J]. AIDS Res Hum Retrovi-ruses, 16, 1067-1073. doi: 10.1089/08892220050075336
Rogers GN, Pritchett TJ, Lane JL, Paulson JC, 1983: Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants[J]. Virology, 131, 394-408. doi: 10.1016/0042-6822(83)90507-X
Scalzo AA, 2002: Successful control of viruses by NK cells--a balance of opposing forces?[J]. Trends Microbiol, 10, 470-474. doi: 10.1016/S0966-842X(02)02441-1
Spies T, Groh V, 2006: Natural cytotoxicity receptors: influenza virus in the spotlight[J]. Nat Immunol, 7, 443-444. doi: 10.1038/ni0506-443
Su S, Bi Y, Wong G, Gray GC, Gao GF, Li S, 2015: Epidemiology, Evolution, and Recent Outbreaks of Avian Influenza Virus in China[J]. J Virol, 89, 8671-8676. doi: 10.1128/JVI.01034-15
Sun Y, Liu J, 2015: H9N2 influenza virus in China: a cause of concern[J]. Protein Cell, 6, 18-25. doi: 10.1007/s13238-014-0111-7
Tam JS, 2002: Influenza A (H5N1) in Hong Kong: an overview[J]. Vaccine, 20, S77-S81.
Thomas JK, Noppenberger J, 2007: Avian influenza: a review[J]. Am J Health Syst Pharm, 64, 149-165. doi: 10.2146/ajhp060181
Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S, 2005: Probable person-to-person transmission of avian influenza A (H5N1)[J]. N Engl J Med, 352, 333-340. doi: 10.1056/NEJMoa044021
Van Kerkhove MD, 2013: Brief literature review for the WHO global influenza research agenda--highly pathogenic avian influenza H5N1 risk in humans[J]. Influenza Other Respir Viruses, 7, 26-33.
Wang H, Feng Z, Shu Y, Yu H, Zhou L, Zu R, Huai Y, Dong J, Bao C, Wen L, Wang H, Yang P, Zhao W, Dong L, Zhou M, Liao Q, Yang H, Wang M, Lu X, Shi Z, Wang W, Gu L, Zhu F, Li Q, Yin W, Yang W, Li D, Uyeki TM, Wang Y, 2008: Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China[J]. Lancet, 371, 1427-1434. doi: 10.1016/S0140-6736(08)60493-6
Webster RG, Govorkova EA, 2006: H5N1 influenza--continuing evolution and spread[J]. N Engl J Med, 355, 2174-2177. doi: 10.1056/NEJMp068205
WHO , 2006: Epidemiology of WHO-confirmed human cases of avian influenza A (H5N1) infection[J]. Wkly Epidemiol Rec, 81, 249-257.
WHO. 2015. Cumulative number of confirmed human cases for avian influenza A (H5N1) reported to WHO, 2003-2015. Available: http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/. Accessed 23 November 2016.
Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Cheung PT, To WK, Ho ET, Sung R, Cheng AF, 1998: Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus[J]. Lancet, 351, 467-471. doi: 10.1016/S0140-6736(98)01182-9
Zhang KY, Zhu L, Bai JG, Han ZY, Guo HM, Zhang ZP, Zhu QY, 2012: Altered lymphocyte counts in a pediatric patient with H5N1 infection[J]. Pediatr Emerg Care, 28, 921-923. doi: 10.1097/PEC.0b013e318267f419
Zocchi MR, Rubartelli A, Morgavi P, Poggi A, 1998: HIV-1 Tat inhibits human natural killer cell function by blocking L-type calcium channels[J]. J Immunol, 161, 2938-2943.